Morgan Stanley
GLSI icon

Morgan Stanley’s Greenwich LifeSciences GLSI Stock Holding History

Morgan Stanley’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
43,447
+13,620
+46% +$331K ﹤0.01% 5201
2026
Q1 		$716K Buy
29,827
+3,448
+13% +$89.9K ﹤0.01% 5302
2025
Q4 		$554K Buy
26,379
+17,658
+202% +$186K ﹤0.01% 5453
2025
Q3 		$86.8K Sell
8,721
-3,045
-26% -$34.4K ﹤0.01% 6216
2025
Q2 		$107K Buy
11,766
+2,219
+23% +$21.1K ﹤0.01% 6104
2025
Q1 		$91.1K Sell
9,547
-4,227
-31% -$51.3K ﹤0.01% 6055
2024
Q4 		$155K Sell
13,774
-3,257
-19% -$43.6K ﹤0.01% 5877
2024
Q3 		$245K Buy
17,031
+9,978
+141% +$148K ﹤0.01% 5678
2024
Q2 		$122K Buy
7,053
+823
+13% +$12K ﹤0.01% 5891
2024
Q1 		$124K Buy
6,230
+5,950
+2,125% +$73.4K ﹤0.01% 5905
2023
Q4 		$2.95K Hold
280
– – ﹤0.01% 6965
2023
Q3 		$2.48K Sell
280
-477
-63% -$4.48K ﹤0.01% 7082
2023
Q2 		$7.3K Sell
757
-6,366
-89% -$71.2K ﹤0.01% 6904
2023
Q1 		$98.2K Sell
7,123
-1,600
-18% -$25.4K ﹤0.01% 6008
2022
Q4 		$133K Sell
8,723
-26,512
-75% -$304K ﹤0.01% 5855
2022
Q3 		$321K Sell
35,235
-37,955
-52% -$351K ﹤0.01% 5493
2022
Q2 		$619K Buy
73,190
+51,483
+237% +$590K ﹤0.01% 5314
2022
Q1 		$426K Sell
21,707
-14,451
-40% -$292K ﹤0.01% 5508
2021
Q4 		$879K Buy
36,158
+35,461
+5,088% +$1.19M ﹤0.01% 5165
2021
Q3 		$27K Sell
697
-7,704
-92% -$322K ﹤0.01% 6977
2021
Q2 		$378K Buy
8,401
+3,779
+82% +$143K ﹤0.01% 5694
2021
Q1 		$158K Buy
4,622
+819
+22% +$27.9K ﹤0.01% 5788
2020
Q4 		$138K Buy
+3,803
New +$55.5K ﹤0.01% 5775

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Morgan Stanley's GLSI Position: Q2 2026 in Review

Morgan Stanley increased its Greenwich LifeSciences (GLSI) stake by 46% in Q2 2026, buying an estimated $331K and bringing the position to 43,447 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #5201.

Morgan Stanley first reported a position in GLSI in Q4 2020 and has held it in 23 quarters since. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Morgan Stanley held 43,447 shares of Greenwich LifeSciences worth $1.02M as of Q2 2026.
  • Morgan Stanley bought 13,620 Greenwich LifeSciences shares in Q2 2026, an estimated $331K.
  • Greenwich LifeSciences made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5201 holding.
  • Morgan Stanley first reported a position in Greenwich LifeSciences in Q4 2020 and has held it in 23 quarters since.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.